The role of gemcitabine in the treatment of other tumours
about
Raynaud's Phenomenon: A Brief Review of the Underlying MechanismsPhase II study of weekly gemcitabine in patients with metastatic breast cancer relapsing or failing both an anthracycline and a taxane.Phase II study of gemcitabine and cisplatin in the treatment of patients with advanced pancreatic carcinoma.Gemcitabine twice weekly as a radiosensitiser for the treatment of brain metastases in patients with carcinoma: a phase I studySalvage chemotherapy with gemcitabine and oxaliplatin in heavily pretreated patients with metastatic breast cancer: a multicenter phase II study.Biweekly vinorelbine and gemcitabine as second-line and beyond treatment in ovarian cancer.Comparison of pemetrexed plus cisplatin with gemcitabine plus docetaxel in refractory/metastatic osteosarcoma: Clinical outcomes from a retrospective database monitored in a single instituteSynergistic effects of nanosecond pulsed electric fields combined with low concentration of gemcitabine on human oral squamous cell carcinoma in vitro.Antimetabolite incorporation into DNA: structural and thermodynamic basis for anticancer activity.The C-terminal region of Bfl-1 sensitizes non-small cell lung cancer to gemcitabine-induced apoptosis by suppressing NF-κB activity and down-regulating Bfl-1.Drug therapy of cancer.Gemcitabine pharmacogenomics: deoxycytidine kinase and cytidylate kinase gene resequencing and functional genomics.Annexin II overexpression predicts rapid recurrence after surgery in pancreatic cancer patients undergoing gemcitabine-adjuvant chemotherapy.Sublethal concentrations of gemcitabine (2',2'-difluorodeoxycytidine) alter mitochondrial ultrastructure and function without reducing mitochondrial DNA content in BxPC-3 human pancreatic carcinoma cells.Mechanism for induction of hydroxyurea resistance and loss of latent EBV genome in hydroxyurea-treated Burkitt's lymphoma cell line Raji.Synergistic effect of sequential administration of mitoguazone (MGBG) and gemcitabine in treating tissue cultured human breast cancer cells and mammary rat tumors.A phase I human trial of mitoguazone and gemcitabine sequential bi-weekly treatment of cancer patients.Intravesical administration of gemcitabine in superficial bladder cancer: a phase I study with pharmacodynamic evaluation.Elevated interferon-induced protein with tetratricopeptide repeats 3 (IFIT3) is a poor prognostic marker in pancreatic ductal adenocarcinoma.
P2860
Q28067805-520710F9-A76F-4958-839C-22DCD35BDFF8Q33182035-912F8B6D-B3C5-4595-846D-D65D5D2B2D73Q33338535-E0A1EB47-495A-4A79-A377-EF1B75877B08Q33365043-C2A78032-C0E3-4DED-9974-2C662D44B3A6Q33373017-C78300B2-C56E-4797-A410-2BA9B84911D6Q33388567-758F4015-3891-40B8-8625-6087C8530A67Q33418020-9F3E2EBB-5188-4DF8-8C07-FA7D8AECB8ADQ34395614-FDFF6327-D00D-45A4-A2CC-9F6A86C3FC43Q34850202-0E271F85-AFE9-4294-8B93-2DE14031443AQ35194201-FA249D10-AC9F-49FA-9BE5-5E60C0311B96Q37845248-24F2BAAE-6DE7-416E-AFE0-305FC331DA88Q38500539-04C0A8CF-9B45-477B-8399-526577C6CB9AQ39949416-BDA23493-0D2B-4913-BB29-B937E6FE947CQ39997145-09647C82-88C7-4E8A-A273-8DD239D05200Q40540953-70D5FBD3-B766-4562-AABE-D3B3DC2599C2Q44439083-6B822C54-835A-499E-A78B-912584446B15Q44610564-5F1EEFF2-0F4C-4FCE-AD86-DC07911363DAQ44791621-10FAF911-C59B-4374-8718-5F78E1045522Q48225102-6DE19B83-E8A5-460D-A55C-0864D7A19293
P2860
The role of gemcitabine in the treatment of other tumours
description
1998 nî lūn-bûn
@nan
1998年の論文
@ja
1998年学术文章
@wuu
1998年学术文章
@zh-cn
1998年学术文章
@zh-hans
1998年学术文章
@zh-my
1998年学术文章
@zh-sg
1998年學術文章
@yue
1998年學術文章
@zh
1998年學術文章
@zh-hant
name
The role of gemcitabine in the treatment of other tumours
@ast
The role of gemcitabine in the treatment of other tumours
@en
type
label
The role of gemcitabine in the treatment of other tumours
@ast
The role of gemcitabine in the treatment of other tumours
@en
prefLabel
The role of gemcitabine in the treatment of other tumours
@ast
The role of gemcitabine in the treatment of other tumours
@en
P2860
P356
P1476
The role of gemcitabine in the treatment of other tumours
@en
P2093
J Carmichael
P2860
P2888
P356
10.1038/BJC.1998.750
P407
P478
78 Suppl 3
P577
1998-01-01T00:00:00Z